BOCCELLATO, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 300
EU - Europa 113
AS - Asia 70
SA - Sud America 1
Totale 484
Nazione #
US - Stati Uniti d'America 298
IT - Italia 36
IE - Irlanda 31
CN - Cina 29
SE - Svezia 19
SG - Singapore 18
UA - Ucraina 10
IN - India 7
VN - Vietnam 6
BY - Bielorussia 4
FR - Francia 4
KR - Corea 4
PL - Polonia 4
CA - Canada 2
HK - Hong Kong 2
RO - Romania 2
AR - Argentina 1
BE - Belgio 1
DE - Germania 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 484
Città #
Chandler 78
Dublin 31
Fairfield 19
Singapore 15
Ashburn 11
Houston 10
Beijing 9
Nyköping 9
Torino 9
Ann Arbor 7
Hangzhou 7
Medford 7
Princeton 7
New York 6
Seattle 6
Cambridge 5
Chennai 5
Wilmington 5
Bologna 4
Canelli 4
Dong Ket 4
Jacksonville 4
San Mateo 4
Seoul 4
Warsaw 4
Fremont 3
Guangzhou 3
Guiyang 3
Redwood City 3
San Diego 3
Upper Marlboro 3
Boston 2
Hebei 2
Hong Kong 2
Milan 2
Nanjing 2
Norwalk 2
Rome 2
Turin 2
Woodbridge 2
Aiello Del Sabato 1
Bad Endorf 1
Brussels 1
Buenos Aires 1
Chengdu 1
Chicago 1
East Brunswick 1
Fort Collins 1
Izmir 1
Jaipur 1
Leawood 1
Los Angeles 1
Montreal 1
Pune 1
Riverton 1
Silver Spring 1
Toronto 1
Venezia 1
Washington 1
Totale 329
Nome #
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs 94
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 84
Real life use of bendamustine in elderly patients with lymphoid neoplasia 79
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 60
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 58
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 50
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia 47
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia 18
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 13
Totale 503
Categoria #
all - tutte 1.935
article - articoli 0
book - libri 0
conference - conferenze 214
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 1 5
2020/2021108 1 4 3 7 16 4 10 10 13 4 2 34
2021/2022129 9 7 12 6 10 2 10 2 4 12 29 26
2022/2023172 19 18 3 16 14 42 9 11 24 3 6 7
2023/202482 10 15 5 3 2 21 0 3 1 6 8 8
2024/20256 3 3 0 0 0 0 0 0 0 0 0 0
Totale 503